Current etf page

ETF Context

XBI ETF Context

News · Liquidity · Exposure · AIQ Momentum

Financial ServicesAsset ManagementScore data as of Oct 30, 2026

XBIState Street SPDR S&P Biotech ETF

Financial Services / Asset Management

Low Priority

Above Peers

NeutralEdge 7/10
$155.98−$1.81 (−1.15%)

Latest quote

  • Momentum
    70
  • Value
    48
  • Quality
    65
  • Risk resilience
    56
  • Sentiment
    —
algovestiq.comScore data as of Oct 30, 2026

ETF Context Board

News pressure, liquidity, fund structure, exposure, and AIQ momentum context.

Fund profile
Jan 31, 2006

Inception date from the ETF info snapshot.

AIQ Context
AIQ 60/100

Momentum 70/100 and sentiment — beside current fund and news context.

Recent coverage
5 articles

Updated Oct 30, 2026 · Sentiment 34.51%

ETF Context Read

Fund exposure, liquidity, news pressure, and the AIQ components most likely to react first.

Current ETF setup

Primary exposureHealthcare (99.28%)

Largest available fund exposure bucket.

Expense ratio0.35%

Cost context that can affect long-term fund returns.

Average volume9M

Liquidity context for entry and exit conditions.

Holdings source dateSep 12, 2026

Latest source date for reported holdings.

Sentiment score—

News pressure around the ETF setup.

Momentum score70

Where market reaction would show up first.

AIQ score60/100

Composite decision read before confirmation.

Fund context

Issuer
SPDR

Fund sponsor from the ETF info snapshot.

Asset class
Equity

Broad asset class for the ETF.

Primary exposure
Healthcare (99.28%)

Largest available exposure bucket.

Fund size
$8.16B

Current assets under management when provided.

Expense ratio
0.35%

Annual fund cost reported by the provider.

Holdings
156

Number of positions the fund holds.

Average volume
9M

Liquidity context from the ETF info snapshot.

Holdings source date
Sep 12, 2026

Latest holder snapshot source date.

Institutional Holder Changes

Filing-reported ETF share ownership changes by holder; this is not intraday flow or constituent trading.

Largest reported increases

No downstream institutional holder changes are available for this ETF yet.

Largest reported decreases

No downstream institutional holder changes are available for this ETF yet.

News And Sentiment

Recent ETF coverage, scored where source sentiment is available.

Positive
3
Neutral
1
Negative
1
zacks.com · Oct 26, 2026

Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?

Sector ETF report for XBI

zacks.com · Sep 29, 2026

Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

Smart Beta ETF report for XBI

finance.yahoo.com · Sep 23, 2026

How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?

Incyte is gaining momentum, recently outperforming the biotech sector and keeping analysts broadly positive on the stock.

rttnews.com · Sep 9, 2026

Biotech Movers: Modular Medical Jumps, InnovAge Revenue Up 16%, Pyxis Data On Deck, Dogwood In Focus

With heightened trade tensions between the U.S. and Canada and rising oil prices weighing on investor sentiment, U.S. stocks came under pressure on Tuesday. Now, let's take a look at some of the biotech and pharmaceutical companies that gained in overnight trading on Tuesday.

seekingalpha.com · Sep 5, 2026

XBI: Big Pharma Can Keep The 76% Rally Going (NYSEARCA:XBI)

Buy XBI? Get outlook for the SPDR S&P Biotech ETF—8%–14% return target, M&A tailwinds, key risks, and volatility factors.

Open full news and sentiment

XBI ETF Context FAQ

What can move XBI ETF?

XBI can move with its underlying holdings, sector exposure, index or strategy rules, market liquidity, distributions, rates, volatility, and ETF-specific news. Use ETF context with AIQ momentum and risk evidence rather than company earnings.

What should XBI ETF investors watch next?

XBI investors should watch changes in fund exposure, holdings concentration, liquidity, distribution updates, market regime, and news pressure around the ETF's strategy.

Does XBI ETF have earnings?

XBI is an ETF, so it does not report company earnings. Its setup is driven by the fund's holdings, strategy, distributions, fees, liquidity, and the market behavior of the securities it owns.

What could drive XBI ETF higher?

XBI could move higher if its underlying holdings, sector exposure, strategy factors, market liquidity, or AIQ momentum improve relative to current expectations.

What risks could hurt XBI ETF?

XBI can be hurt by weakness in its underlying holdings, concentrated exposure, lower liquidity, distribution changes, higher volatility, rate pressure, or a risk-off market regime.